Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Ecopipam (development codes SCH-39166, EBS-101, and PSYRX-101) is a dopamine antagonist which is under development for the treatment of Lesch–Nyhan syndrome, Tourette syndrome, speech disorders, and restless legs syndrome. It is taken by mouth.
The analysis highlights Research and Standards as prominent areas in the source structure around Ecopipam.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Ecopipam shows recurring relationship patterns in the source. For example, Ecopipam → Based, D2, However, Human, Open-label, Parkinsonian-like, Side, There Another extracted example is Ecopipam → D1, D2-like, D5, HT2, It. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
dopamine syndrome treatment antagonist receptor tourette effects drug disorders also development restless legs d1 anxiety receptors side d2 antagonists use
TTTA extracted 31 structured relationships around Ecopipam. Examples in this analysis include Ecopipam → 3D model (JSmol) → Interactive image and Ecopipam → ATC code → none. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Ecopipam | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Ecopipam | ATC code | none | 1.00 | infobox |
| Ecopipam | CAS Number | 112108-01-7 Y | 1.00 | infobox |
| Ecopipam | ChemSpider | 97053 | 1.00 | infobox |
| Ecopipam | CompTox Dashboard (EPA) | DTXSID8043814 | 1.00 | infobox |
| Ecopipam | Elimination half-life | 10 hours | 1.00 | infobox |
| Ecopipam | Formula | C19H20ClNO | 1.00 | infobox |
| Ecopipam | IUPHAR/BPS | 3304 | 1.00 | infobox |
| Ecopipam | Legal status | Investigational | 1.00 | infobox |
| Ecopipam | Molar mass | 313.83 g·mol−1 | 1.00 | infobox |
| Ecopipam | Other names | EBS-101; PSYRX-101; SCH-39166 | 1.00 | infobox |
| Ecopipam | PubChem CID | 107930 | 1.00 | infobox |
| Ecopipam | Routes of administration | By mouth | 1.00 | infobox |
| Ecopipam | UNII | 0X748O646K | 1.00 | infobox |
| Ecopipam | is a | experimental drug and has not been approved for medical use | 0.90 | text |
| Ecopipam | is a | synthetic benzazepine derivative | 0.90 | text |
The concept neighborhoods around Ecopipam bring nearby vocabulary together. In this analysis, examples include Treatment, Syndrome and Antagonist. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Ecopipam, one of the stronger structural bridges in this analysis connects Ecopipam with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Ecopipam to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Research & Standards, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Ecopipam · EN edition · Analysis: TopicsToTalkAbout